Clinical Trial Update: Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update reporting completion and posted results for dapagliflozin on 24-hour blood glucose in adults with type 2 diabetes inadequately c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: AstraZeneca | Conditions: Type II Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2017-04-11